all report title image

QUERCETIN DIHYDRATE MARKET ANALYSIS

Quercetin Dihydrate Market, by Product Type (Powder and Solution), by Application, (Atherosclerosis, Chronic Infections, Cosmetics, Nutraceuticals, Allergy & Inflammation, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

  • To Be Published : Nov 2024
  • Code : CMI2311
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Quercetin is a plant flavonoid found in variety of fruits, vegetables, grains, and leaves. It is used as an ingredient in nutritional supplements and prepared foods. Quercetin dihydrate is formed by removing moisture from quercetin, which is more effective and highly concentrated form of the compound. Quercetin is marketed as a nutritional supplement and helps in reducing inflammation, allergies, and body fat.

Quercetin Dihydrate Market– Drivers

Increasing research activities to identify novel uses of quercetin dihydrate for treating various diseases can be expected to boost growth of the quercetin dihydrate market during forecasted period. For instance, research published in Public Library of Science (PLOS One) Journal in March 2017, reveals that quercetin may be effective in blocking inflammatory compounds released by mast cells during allergic conditions and it is useful in managing allergic rhinitis.

Furthermore, research published in Nutrition Research journal in January 2018 states, quercetin supplementations may boost the antioxidants of body to defend against infections and can be useful in protecting exercise-induced oxidative damage of body. This is attributed to the fact that quercetin supplementation was associated with significant reduction in lipid peroxidation in red blood cells.

Moreover, rising approvals for use of quercetin dihydrate in tablet manufacturing as bulking agent in drug compounding is expected to propel growth of the quercetin dihydrate market during the forecasted year. For instance, in July 2018, U.S. Food and Drug Administration (USFDA) approved quercetin dihydrate as one of the ingredient as a bulk forming agent in the drug compounding.    

Quercetin Dihydrate Market– Regional Analysis

On the basis of region, the global quercetin dihydrate market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is projected to be the leading region in the global quercetin dihydrate market during the forecast period due to rising exhibitions of buyers and suppliers from the dietary supplement, beverage, functional food, personal care, and sports nutrition industries. For instance, SupplySide West 2018 organized in November 2018 in the U.S. where, Indena S.p.A. introduced Quercefit. Quercefit was designed for sports nutrition positioning, by using phytosome delivery system. This system allows more bioavailability and high absorption of quercetin.

Key players operating in the quercetin dihydrate market include Sisco Research Laboratories Pvt. Ltd., Hunan Yuantong Pharmaceutical Co., Ltd, TCI Chemicals (India) Pvt. Ltd., Prinova Group LLC., PVP Sociedade Anonima, Baoji Herbest Bio-Tech Co., Ltd., Chengdu Biopurify Phytochemicals Ltd., Apollo Scientific Ltd., and Aceto Corporation.

Quercetin Dihydrate Market– Taxonomy

By Product Type

  • Powder
  • Solution

By Application

  • Atherosclerosis
  • Chronic Infections
  • Cosmetics
  • Nutraceuticals
  • Allergy & Inflammation
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa

Share

About Author

Ghanshyam Shrivastava - With over 20 years of experience in the management consulting and research, Ghanshyam Shrivastava serves as a Principal Consultant, bringing extensive expertise in biologics and biosimilars. His primary expertise lies in areas such as market entry and expansion strategy, competitive intelligence, and strategic transformation across diversified portfolio of various drugs used for different therapeutic category and APIs. He excels at identifying key challenges faced by clients and providing robust solutions to enhance their strategic decision-making capabilities. His comprehensive understanding of the market ensures valuable contributions to research reports and business decisions.

Ghanshyam is a sought-after speaker at industry conferences and contributes to various publications on pharma industry.

Missing comfort of reading report in your local language? Find your preferred language :

Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Select a License Type





Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.